Pelthos Therapeutics (PTHS) Profit After Tax (2023 - 2026)

Pelthos Therapeutics' Profit After Tax history runs 3 years deep, the most recent figure standing at -$21.7 million for Q4 2025.

• In Q4 2025, Profit After Tax fell 1024.82% year-over-year to -$21.7 million; the TTM figure through Dec 2025 stood at -$43.3 million (down 444.55% YoY), while the FY2025 annual figure was -$43.3 million, down 444.55% from the prior year.
• Profit After Tax for Q4 2025 stood at -$21.7 million, down from -$16.2 million in the prior quarter.
• The five-year high for Profit After Tax was -$953347.0 in Q2 2023, with the low at -$21.7 million in Q4 2025.
• The 3-year median for Profit After Tax is -$1.9 million (2024), against an average of -$4.9 million.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 52.32% in 2024, then sank 1024.82% in 2025.
• Pelthos Therapeutics' Profit After Tax stood at -$4.0 million in 2023, then soared by 52.32% to -$1.9 million in 2024, then tumbled by 1024.82% to -$21.7 million in 2025.
• Business Quant data shows PTHS's Profit After Tax at -$21.7 million in Q4 2025, -$16.2 million in Q3 2025, and -$3.4 million in Q2 2025.